Tabelas de Dose  ›  TB-500
Healing & Recovery

TB-500 Guia & Tabela de Dose

A synthetic fragment of Thymosin Beta-4 researched for cell migration, angiogenesis and recovery.

Também conhecido comoThymosin Beta-4 fragment
Meia-vida~2-3 h
Viasubcutaneous
TB-500 — Tabela de dose
Cada linha citada
ObjetivoDoseFrequênciaDuraçãoEvidênciaFonte
Loading phase 2–2.5 mg 2×/week 4–6 weeks Preclinical PMID 22449788
Maintenance 2 mg 1×/week ongoing Anecdotal PMID 22449788
Apenas para fins de pesquisa e educação. Não é aconselhamento médico.

What is TB-500?

TB-500 is a synthetic research peptide. It is a fragment of a naturally occurring protein called Thymosin Beta-4 (Tβ4). Thymosin Beta-4 was first chemically characterized in 1982 — scientists confirmed it is a 43-amino-acid peptide found throughout the body, including in the thymus gland.[6] TB-500 is the lab-made version of the most biologically active portion of that full protein.

TB-500 belongs to the Healing & Recovery category of research peptides. In short: it is studied for its potential to help cells move, new blood vessels form, and tissues repair. It is a research compound only — it is not approved for human medical use, and nothing here is medical advice.

How TB-500 Works

Think of your body's healing process like a construction crew. When something is damaged — a tendon, a blood vessel, a patch of tissue — your body sends out signals to recruit workers, lay new pipes (blood vessels), and rebuild the structure. TB-500 appears to influence several of those signals at once.

At the molecular level, TB-500 — like its parent molecule Thymosin Beta-4 — is known as an actin-sequestering peptide. Actin is a protein that acts like scaffolding inside cells. By binding to free actin, TB-500 helps control how cells change shape and move around.[6] That ability to influence cell movement is central to wound healing: cells need to migrate to the site of damage before repairs can begin.

Research also points to TB-500's role in angiogenesis — the growth of new blood vessels. New vessels bring oxygen and nutrients to healing tissue. Reviews of peptide therapies in sports medicine and orthopaedics describe TB-500 as a compound that promotes angiogenesis, integrin-mediated extracellular matrix remodeling (rebuilding the structural web that holds tissue together), and fibroblast activation (fibroblasts are the cells that lay down new connective tissue).[2]

There is also early cell-based research showing that Thymosin Beta-4 helps stabilize the blood-brain barrier — the tight seal of cells that protects the brain. In lab experiments using human brain endothelial cells, Tβ4 increased the expression of protective tight-junction proteins and reduced harmful changes to the cell's internal scaffolding.[5] This line of research is still early-stage, but it hints at a broader role in protecting and maintaining cellular structures.

What the Research Shows

It is important to be upfront: most TB-500 research is preclinical, meaning it has been done in cells or animals, not in large human trials.

A 2026 review published in the American Journal of Sports Medicine examined injectable peptide therapies and noted that TB-4 and its derivative TB-500 promoted angiogenesis and tissue repair in preclinical models — but concluded that human orthopaedic data are lacking, and that both remain banned substances in competitive sports.[3]

A separate 2026 narrative review in Sports Medicine listed TB-500 among unapproved peptides that show favorable tissue repair outcomes in animal models, while stressing that rigorous human safety data are scarce.[4]

On the orthopaedic side, a 2021 retrospective case series looked at intra-articular injections combining BPC-157 and TB4 (the full protein) for knee pain. Of the four patients who received both peptides, 75% reported significant improvement — though the study was very small, lacked controls, and the authors acknowledged it was preliminary.[1]

A 2026 orthopaedic review summarized TB-500 as a wound-healing peptide with mechanisms touching key signaling pathways including PI3K/Akt, mTOR, and TGF-β — all involved in tissue regeneration and inflammation resolution — while noting the current lack of clinical trials.[2]

What TB-500 Is Being Studied For

  • Tissue repair and wound healing — accelerating the body's natural recovery processes at the cellular level[2]
  • Angiogenesis — stimulating the growth of new blood vessels into damaged tissue[3]
  • Musculoskeletal recovery — tendons, ligaments, and connective tissue repair in orthopaedic research contexts[4]
  • Cell migration — helping repair cells travel to sites of damage via actin-modulating activity[6]
  • Barrier protection — early cellular research into maintaining tight-junction integrity in endothelial cells[5]

How TB-500 Is Dosed in Research

Research protocols for TB-500 typically follow a two-phase approach. A loading phase uses higher, more frequent doses to build up the compound, followed by a lower maintenance phase. The specific milligram amounts, frequencies, and durations used in research settings are laid out in the dosage chart on this page — and you can use the calculator to work out volumes based on your reconstitution concentration. Keep in mind that researchers note dosing information for TB-500 in humans has not been formally validated in clinical trials, and optimal protocols remain unknown.[3]

Mixing and Storing TB-500

TB-500 typically arrives as a lyophilized powder — a freeze-dried white or off-white solid in a sealed vial. To use it in a research setting, it must be reconstituted, meaning dissolved in a liquid. Bacteriostatic water (sterile water with a small amount of benzyl alcohol to prevent bacterial growth) is the standard choice for reconstitution, as it allows the solution to be stored for several weeks without spoiling.

When adding liquid, aim the syringe at the side wall of the vial — not directly onto the powder — and let the water trickle down gently. Do not shake the vial; swirl it slowly or let it dissolve on its own. Shaking can break down the delicate peptide chain.

Once reconstituted, store the vial in a refrigerator (2–8 °C / 36–46 °F), away from light. Unreconstituted powder is more stable and can typically be kept frozen for longer periods. Always follow the storage guidance that comes with your specific research-grade product, and discard any solution that looks cloudy, discolored, or contains particles.

Sources

  1. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. — Alternative therapies in health and medicine, 2021. PMID 34324435.
  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. — Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200.
  3. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. — The American journal of sports medicine, 2026. PMID 41476424.
  4. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. — Sports medicine (Auckland, N.Z.), 2026. PMID 41966639.
  5. Thymosin beta 4 attenuates PrP(106-126)-induced human brain endothelial cells dysfunction. — European journal of pharmacology, 2020. PMID 31877278.
  6. Chemical characterization of thymosin beta 4. — The Journal of biological chemistry, 1982. PMID 7054160.

TB-500 Perguntas

What is TB-500?
TB-500 is a synthetic research peptide derived from Thymosin Beta-4, a naturally occurring 43-amino-acid protein first characterized in 1982.[6] It is the lab-made fragment of the most active portion of that protein. Researchers study it for its potential roles in cell migration, angiogenesis (new blood vessel growth), and tissue repair. It is not approved for human medical use and is classified as a research compound only.[4]
How does TB-500 work?
TB-500 works by binding to free actin — a scaffolding protein inside cells — which helps regulate how cells move and change shape, a key part of wound healing.[6] It also appears to promote angiogenesis and activate fibroblasts (cells that build connective tissue), and may support integrin-mediated remodeling of the extracellular matrix — the structural web that holds tissue together.[2]
What is TB-500 used for in research?
In research settings, TB-500 is studied for tissue repair, angiogenesis, musculoskeletal recovery, and cell migration.[2][3] Early cell-based studies also explore its role in protecting barrier function in endothelial cells.[5] Most evidence comes from preclinical (animal and cell) models; human clinical data are currently very limited, and researchers stress that more trials are needed before any conclusions can be drawn.[4]
How is TB-500 dosed in research?
Research protocols typically use a loading phase followed by a lower-dose maintenance phase — see the dosage chart on this page for specifics. Importantly, a 2026 sports medicine review noted that optimal dosing, frequency, and duration for TB-500 in humans have not been formally established in clinical trials.[3] The calculator on this page can help researchers work out volumes after reconstitution.
How do you reconstitute TB-500?
TB-500 powder is dissolved in bacteriostatic water. Add the liquid slowly down the side wall of the vial — do not shake it, as this can degrade the peptide. Swirl gently until dissolved. Store the reconstituted solution refrigerated at 2–8 °C, away from light. Lyophilized (freeze-dried) powder is more stable and can be kept frozen before mixing. Discard any solution that appears cloudy or discolored.
Is TB-500 safe?
Rigorous human safety data for TB-500 are currently scarce.[4] A 2026 review warned that unapproved peptides like TB-500 carry potential for serious harm, since they operate largely outside regulatory oversight.[4] TB-500 is also a banned substance in competitive sports.[3] It is a research-only compound, and nothing on this page constitutes medical advice. Always consult a qualified healthcare professional before considering any peptide compound.